Related Experiment Videos
The prognostic implication of hypercholesterolemia in infants and children with hepatoblastoma
Insights
High serum cholesterol levels in infants with hepatoblastoma may indicate a poor prognosis. This study suggests pretreatment cholesterol is a significant factor in outcomes for pediatric hepatoblastoma patients.
Area of Science:
- Pediatric Oncology
- Biochemistry
Background:
- Hepatoblastoma is a rare liver cancer primarily affecting young children.
- The role of serum cholesterol in hepatoblastoma prognosis is not well-established.
Purpose of the Study:
- To investigate the relationship between pretreatment serum cholesterol levels and patient outcomes in hepatoblastoma.
Main Methods:
- Retrospective analysis of nine pediatric hepatoblastoma cases.
- Correlation of pretreatment serum cholesterol levels (normal, moderately elevated, high) with tumor type, treatment response, and survival.
Main Results:
- Four patients with high cholesterol (417-544 mg%) and epithelial tumors had poor outcomes, with three deaths.
- Two patients with normal cholesterol levels achieved long-term survival after treatment.
- Outcomes varied for patients with moderately elevated cholesterol.
Conclusions:
- Pretreatment serum cholesterol levels may serve as a prognostic indicator in pediatric hepatoblastoma.
- Further research is warranted to confirm the prognostic value of cholesterol in hepatoblastoma.
Abstract:
This paper reports the relationship between serum cholesterol level and hepatoblastoma in nine patients. Four of the nine patients had a high (417-544 mg%) serum cholesterol. All of these patients were less than one year of age and had tumors of the epithelial type. Three of the infants died soon after being diagnosed. Three patients had a moderately elevated serum cholesterol (206-249mg%). One underwent primary hepatic resection. Two had nonresectable tumors that became resectable after chemotherapy. One died secondary to pulmonary metastases. The remaining two patients had a normal serum cholesterol level prior to treatment. Both patients had hepatic resection after chemotherapy and had no evidence of increased cholesterol postoperatively and are alive six years after diagnosis. From these data, it is suggested that the pretreatment level of serum cholesterol may be of prognostic significance in infants and children with hepatoblastoma.